164. Oculocutaneous albinism Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 15 / Drugs : 54 - (DrugBank : 34) / Drug target genes : 35 - Drug target pathways : 141
Oculocutaneous albinism and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
164 | Oculocutaneous albinism | - |
13 | Multiple sclerosis/Neuromyelitis optica | 20.480 |
46 | Malignant rheumatoid arthritis | 16.484 |
51 | Scleroderma | 15.747 |
284 | Diamond-Blackfan anemia | 15.068 |
85 | Idiopathic interstitial pneumonia | 13.428 |
60 | Aplastic anemia | 13.160 |
65 | Primary immunodeficiency | 12.387 |
285 | Fanconi anemia | 12.047 |
222 | Primary nephrotic syndrome | 12.029 |
283 | Acquired pure red cell aplasia | 10.770 |
11 | Myasthenia gravis | 10.541 |
96 | Crohn disease | 10.437 |
50 | Dermatomyositis | 10.353 |
19 | Lysosomal storage disease | 9.494 |
45 | Eosinophilic granulomatosis with Polyangiitis | 9.412 |
41 | Giant cell arteritis | 9.258 |
228 | Bronchiolitis obliterans | 9.258 |
55 | Relapsing polychondritis | 8.824 |
49 | Systemic lupus erythematosus | 8.718 |
62 | Paroxysmal nocturnal hemoglobinuria | 8.672 |
97 | Ulcerative colitis | 8.477 |
20 | Adrenoleukodystrophy | 8.471 |
2 | Amyotrophic lateral sclerosis | 8.317 |
286 | Hereditary sideroblastic anemia | 8.000 |
93 | Primary biliary cholangitis | 7.953 |
95 | Autoimmune hepatitis | 7.867 |
42 | Polyarteritis nodosa | 7.819 |
28 | Systemic amyloidosis | 7.512 |
6 | Parkinson disease | 7.286 |
84 | Sarcoidosis | 7.171 |
58 | Hypertrophic cardiomyopathy | 7.145 |
162 | Pemphigoid | 7.059 |
107 | Juvenile idiopathic arthritis | 6.978 |
53 | Sjogren syndrome | 6.868 |
160 | Congenital ichthyosis | 6.863 |
40 | Takayasu arteritis | 6.833 |
224 | Purpura nephritis | 6.353 |
90 | Retinitis pigmentosa | 6.137 |
299 | Cystic fibrosis | 6.058 |
151 | Rasmussen encephalitis | 6.000 |
234 | Peroxisomal disease (except Adrenoleukodystrophy) | 5.961 |
56 | Behcet disease | 5.833 |
34 | Neurofibromatosis | 5.306 |
269 | Pyogenic arthritis | 5.145 |
38 | Stevens-Johnson syndrome | 5.145 |
302 | Leber hereditary optic neuropathy | 5.000 |
39 | Toxic epidermal necrolysis | 4.979 |
66 | IgA nephropathy | 4.958 |
326 | Osteopetrosis | 4.941 |
26 | HTLV-1-associated myelopathy | 4.799 |
61 | Autoimmune hemolytic anemia | 4.765 |
36 | Epidermolysis bullosa | 4.382 |
113 | Muscular dystrophy | 4.138 |
331 | Idiopathic multicentric castleman disease | 3.461 |
226 | Interstitial cystitis with Hunners ulcer | 3.313 |
44 | Wegener granulomatosis | 3.294 |
35 | Pemphigus | 3.210 |
43 | Microscopic polyangiitis | 3.176 |
227 | Osler disease | 3.133 |
7 | Corticobasal degeneration | 3.105 |
300 | IgG4-related disease | 3.035 |
64 | Thrombotic thrombocytopenic purpura | 2.912 |
74 | Prolactin secreting pituitary adenoma | 2.912 |
4 | Primary lateral sclerosis | 2.619 |
94 | Primary sclerosing cholangitis | 2.619 |
201 | Angelman syndrome | 2.406 |
271 | Ankylosing spondylitis | 2.390 |
309 | Progressive myoclonus epilepsy | 2.316 |
63 | Idiopathic thrombocytopenic purpura | 2.306 |
274 | Osteogenesis Imperfecta | 2.258 |
17 | Multiple system atrophy | 2.079 |
16 | Crow-Fukase syndrome | 1.906 |
158 | Tuberous sclerosis | 1.906 |
140 | Dorabe syndrome | 1.676 |
270 | Chronic recurrent multifocal osteomyelitis | 1.632 |
172 | Hypophosphatasia | 1.373 |
86 | Pulmonary arterial hypertension | 1.355 |
106 | Cryopyrin-associated periodic syndrome | 1.059 |
108 | TNF receptor-associated periodic syndrome | 1.000 |
267 | Hyper-IgD syndrome | 1.000 |
241 | Hypertyrosinemia type I | 1.000 |
220 | Rapidly progressive glomerulonephritis | 1.000 |
30 | Distal myopathy | 1.000 |